Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jun;7(1):e000411.
doi: 10.1136/bmjgast-2020-000411.

Colon capsule endoscopy in colorectal cancer screening: a randomised controlled trial

Lasse Kaalby  1   2 , Ulrik Deding  3   2 , Morten Kobaek-Larsen  3   2 , Anne-Line Volden Havshoi  3 , Erik Zimmermann-Nielsen  3   2 , Marianne Kirstine Thygesen  3   2 , Rasmus Kroeijer  4 , Thomas Bjørsum-Meyer  3 , Gunnar Baatrup  3   2
Affiliations
Randomized Controlled Trial

Colon capsule endoscopy in colorectal cancer screening: a randomised controlled trial

Lasse Kaalby et al. BMJ Open Gastroenterol. 2020 Jun.

Abstract

Introduction: The use of capsule endoscopy has become an approved method in small bowel diagnostics, but the same level of integration is not seen in large bowel diagnostics. We will use colon capsule endoscopy (CCE) as a filter test in colorectal cancer (CRC) screening between the faecal immunochemical test (FIT) and colonoscopy. We aim to investigate the clinical performance, population acceptability, and economic implications of the procedure in a large-scale clinical trial.

Methods and analysis: We will randomly allocate 124 214 Danish citizens eligible for participation in the national CRC screening programme within the Region of Southern Denmark to either an intervention group or a control group. Prior to submitting a FIT, citizens randomised to the intervention group will be informed about their opportunity to undergo CCE, instead of colonoscopy, if the FIT is positive. Suspected cancers; >3 adenomas <10 mm in size, 1 adenoma >10 mm in size or >4 adenomas regardless of size, detected during CCE will generate an invitation to colonoscopy as per regular screening guidelines, whereas citizens with suspected low risk polyps will re-enter the biennial screening programme. Citizens with no CCE findings will be excluded from screening for 8 years. In the control group, citizens will follow standard screening procedures.

Ethics and dissemination: All participants must consent prior to capsule ingestion. All collected data will be handled and stored in accordance with current data protection legislation. Approvals from the regional ethics committee (ref. S-20190100) and the Danish data protection agency have been obtained (ref. 19/29858).

Trial registration details: The study has been registered with ClinicalTrials.gov under: NCT04049357.

Keywords: colorectal adenomas; colorectal cancer screening; diagnostic and therapeutic endoscopy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: GB is financially supported by Medtronic but the company does not influence any scientific processes, and no investigator will receive any personal benefits.

Figures

Figure 1
Figure 1
Expected flow in the intervention and the control group. CCE, colon capsule endoscopy; CRC, colorectal cancer;FIT, faecal immunochemicaltest.
Figure 2
Figure 2
Structure of questionnaire modules. CCE, colon capsule endoscopy.
See this image and copyright information in PMC

References

    1. Navarro M, Nicolas A, Ferrandez A, et al. . Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol 2017;23:3632–42. 10.3748/wjg.v23.i20.3632 - DOI - PMC - PubMed
    1. Kronborg O, Fenger C, Olsen J, et al. . Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71. 10.1016/S0140-6736(96)03430-7 - DOI - PubMed
    1. Shaukat A, Mongin SJ, Geisser MS, et al. . Long-term mortality after screening for colorectal cancer. N Engl J Med 2013;369:1106–14. 10.1056/NEJMoa1300720 - DOI - PubMed
    1. Mandel JS, Bond JH, Church TR, et al. . Reducing mortality from colorectal cancer by screening for fecal occult blood. minnesota colon cancer control study. N Engl J Med 1993;328:1365–71. 10.1056/NEJM199305133281901 - DOI - PubMed
    1. Scholefield JH, Moss SM, Mangham CM, et al. . Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012;61:1036–40. 10.1136/gutjnl-2011-300774 - DOI - PubMed

Publication types

MeSH terms

Associated data